NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Step Pharma

Step Pharma

Private
Saint-Genis-PouillyHealthcare & Life Scienceshttps://step-ph.com/

Last Round

Grant

Feb 19, 2026

Total Funding Raised

$148.58M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Step Pharma is a biotechnology company that develops proprietary small molecule therapeutics designed for the treatment of cancer and autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

CTPS1 inhibitortargeted cancer therapyDencatistatsmall molecule inhibitorprecision oncologyclinical-stage biotechoral oncology drugcytidine triphosphate synthase 1T-cell lymphomaB-cell lymphomablood cancer treatmentsolid tumor treatmentdrug discoverybiomarker identificationpipeline in a product

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Step Pharma Comps

Public and private peers based on sector, stage, and business model.

Step Pharma comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Step Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 19, 2026
Series COct 15, 2025
Series COct 15, 2023
Series BMar 24, 2021
Series ANov 21, 2017
Seed
Jul 30, 2014

Key People

Founding team and executive leadership

Andy Parker

President And Chief Executive Officer

Executive Team

Nicolas Marsault

CFO

Executive Team

Step Pharma Investors

Notable investors and investment history

Step Pharma investors
InvestorRounds
European Innovation Council FundGrant
Idinvest PartnersSeed, Series A
Inserm TransfertSeed, Series C, Series A
Pontifax Venture CapitalSeries B, Series A, Series C
BpifranceSeed, Series B, Series C, Series A
Institut ImagineSeed, Series A
V-Bio VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Secured $2.72M in grant funding.

  • Oct 28, 2025

    Dr. Karen Smith appointed as the new Chief Medical Officer.

Step Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Step Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Step Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint-Genis-Pouilly
Employee Range15
Year Founded2014
Last FundingFeb 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.